GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.62 CNY | +0.27% |
|
-0.27% | -5.08% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 995M 138M | Sales 2023 | 1.28B 178M | Capitalization | 13.21B 1.83B |
|---|---|---|---|---|---|
| Net income 2022 | -399M -55.23M | Net income 2023 | 90M 12.46M | EV / Sales 2022 | 13.9 x |
| Net Debt 2022 | 187M 25.82M | Net Debt 2023 | 32.6M 4.51M | EV / Sales 2023 | 10.3 x |
| P/E ratio 2022 |
-34.3
x | P/E ratio 2023 |
150
x | Employees | 1,950 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.27% | ||
| 1 week | -0.27% | ||
| Current month | -0.27% | ||
| 1 month | +2.48% | ||
| 3 months | +1.63% | ||
| 6 months | -11.13% | ||
| Current year | -5.08% |
1 week
25.45
26.41
1 month
23.3026.41
Current year
20.9127.65
1 year
20.9141.16
3 years
16.4854.04
5 years
11.4854.04
10 years
11.4854.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Bo Wang
DFI | Director of Finance/CFO | 40 | 22-02-27 |
Li Qiao
IRC | Investor Relations Contact | 41 | 23-01-17 |
Yun Tang
SEC | Corporate Secretary | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Tang
SEC | Corporate Secretary | 52 | - |
Xuan Min Zhao
BRD | Director/Board Member | 69 | 20-01-14 |
Bo Yang
BRD | Director/Board Member | 50 | 23-01-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.48% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 25.62 | +0.27% | 4,071,606 |
| 24-05-08 | 25.55 | -1.28% | 5,007,300 |
| 24-05-07 | 25.88 | -0.50% | 5,665,281 |
| 24-05-06 | 26.01 | +1.25% | 7,816,965 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotes
GuangYuYuan Chinese Herbal Medicine Co., Ltd. is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicine and health wine. The Company's products types consist of traditional Chinese medicine, fine Chinese medicine and health wine, which include Dingkun Dan, Guilingji, Angong Niuhuang Pills and Niuhuang Qingxin Pills, among others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.08% | 1.74B | |
| +43.25% | 6.3B | |
| -15.08% | 4.53B | |
| -6.70% | 3.29B | |
| +5.47% | 3.2B | |
| +0.76% | 2.63B | |
| +47.75% | 1.97B | |
| +2.05% | 1.69B | |
| -7.08% | 1.64B | |
| +46.62% | 1.52B |
- Stock Market
- Equities
- 600771 Stock